Yahoo! Finance Search - Finance Home - Yahoo! - Help

Monday, April 20 2015 9:32pm ET - U.S. Markets Closed.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Manufacturers - Major News
Latest News
Monday, Apr 20, 2015
·Final Glance: Pharmaceuticals companies
AP - 2 hours, 20 minutes ago
·Bristol-Myers, Merck Trial Data Bolster New Cancer Drug Class
Investor's Business Daily, Inc. - 2 hours, 27 minutes ago
·AQR Capital Ups Stake in Johnson and Johnson
- Mon 6:07 pm ET
·Bristol, Merck Cancer Drugs Strut Their Stuff
at Investor's Business Daily, Inc. - Mon 5:31 pm ET
·GW Pharmaceuticals Poised For New All-Time High Close On Appropriate Day
- Mon 2:30 pm ET
·Johnson & Johnson to Host Pharmaceutical Business Review
PR Newswire - Mon 2:20 pm ET
·Bristol-Myers combination melanoma treatment shows promise
at FT.com - Mon 1:55 pm ET
·Bristol-Myers: 2 cancer drugs beat 1 against melanoma
AP - Mon 1:21 pm ET
·Midday Glance: Pharmaceuticals companies
AP - Mon 1:17 pm ET
·Is GW Pharmaceuticals the Perfect Cannabis Stock on National Weed Day?
- Mon 11:30 am ET
·Early Glance: Pharmaceuticals companies
AP - Mon 10:38 am ET
·3 Big Pharmaceutical Stocks Will Have Rising Q1 Earnings
- Mon 9:10 am ET
·Immune System Drugs Melt Tumors In New Study, Leading A Cancer Revolution
at Forbes.com - Mon 9:01 am ET
·Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015
PR Newswire - Mon 9:00 am ET
·Cantrixil Highly Successful in Preventing Growth of Chemo-Resistant Ovarian Cancer
PR Newswire - Mon 9:00 am ET
·Bristol-Myers immunotherapy combo promising in melanoma-study
Reuters - Mon 8:30 am ET
·First Randomized Study Evaluating Opdivo (nivolumab)+Yervoy (ipilimumab) Regimen Demonstrates Superior Efficacy Versus Yervoy Alone in Patients with Previously Untreated Advanced Melanoma
Business Wire - Mon 8:30 am ET
·Lilly's psoriatic arthritis drug succeeds in late-stage study
Reuters - Mon 8:13 am ET
·TetraLogic and Merck to Collaborate on the Evaluation of Birinapant in Combination with KEYTRUDA┬« (pembrolizumab) in Solid Tumors
Business Wire - Mon 8:00 am ET
·Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis
PR Newswire - Mon 8:00 am ET
More Latest News...
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Major Headlines
More Finance RSS Feeds


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?